FUNDACION FILS DE LUCHA CONTRA ELSIDA LAS ENFERMEDADES INFECCIOSASY LA PROMOCION DE LA SALUD Y LACIENCIA - ES 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 9.779.211 661.655 1
2020 1.498.790 0 1.150.679 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASPHALION SL1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
EUROPEAN AIDS TREATMENT GROUP EV1
FONDAZIONE PENTA ONLUS1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDACAIXA1
HIPRA HUMAN HEALTH SL1
HIPRA SCIENTIFIC SL1
HOSPITAL CLINIC DE BARCELONA1
LABORATORIOS HIPRA1
METPHARM ARASTIRMA GELISTIRME SAGLIK DANISMANLIK LIMITED SIRKET1
UNIVERSITY OF WASHINGTON1
VERISTAT INTERNATIONAL LIMITED1
VINCES CONSULTING SL1
ZABALA INNOVATION CONSULTING S A1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-12-01RBD Dimer recombinant protein vaccine against SARSCoV2 RBDCOVparticipant9.779.21116
2020-02-01Repurposing clinically approved antibacterial drugs for treponematoses therapy Trep-ABcoordinator1.498.7902